Lennart Minthon (Former)
111 – 120 of 304
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Altered chemokine levels in the cerebrospinal fluid and plasma of suicide attempters.
- Contribution to journal › Article
-
Mark
Multidisciplinary intervention reducing readmissions in medical inpatients: a prospective, non-randomized study
- Contribution to journal › Article
-
Mark
Three-year outcome of rivastigmine treatment in Alzheimer's disease in a routine clinical setting.
(2013) 11th International Conference on Alzheimer’s & Parkinson’s Diseases (AD/PD 2013)
- Contribution to conference › Poster
-
Mark
Living Alone in Alzheimer’s Disease—The Influence of Functional Impairment.
(2013) 6th Clinical Trials Conference on Alzheimer’s Disease (CTAD)
- Contribution to conference › Poster
-
Mark
Plasma tau levels in Alzheimer's disease
- Contribution to journal › Letter
-
Mark
Low CSF Levels of Both α-Synuclein and the α-Synuclein Cleaving Enzyme Neurosin in Patients with Synucleinopathy.
- Contribution to journal › Article
- 2012
-
Mark
A novel ARC gene polymorphism is associated with reduced risk of Alzheimer's disease
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer's disease
- Contribution to journal › Article
-
Mark
A longitudinal study of physical function in patients with early-onset dementia
- Contribution to journal › Article
-
Mark
Age and diagnostic performance of Alzheimer disease CSF biomarkers
- Contribution to journal › Article
